News
📈 Stocks
Thermo Fisher Rallies 8% as Biotech Funding Recovery Drives UBS Upgrade
(2 days ago)
Thermo Fisher gains momentum on strong organic growth and biotech recovery, while Becton Dickinson struggles with regulatory hurdles and higher short interest.